EcoDrugPlus

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSAUG00010014280
Gene Symbol: LOC115578741
3 Cross references
190 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSSAUG00010002205
Gene Symbol: DHODH
3 Cross references
172 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSAUG00010018860
Gene Symbol: LOC115584933
3 Cross references
199 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSSAUG00010018279
Gene Symbol: LOC115583819
3 Cross references
192 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSSAUG00010007417
Gene Symbol: DPYD
3 Cross references
211 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSAUG00010013526
Gene Symbol: DDR2
3 Cross references
204 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSSAUG00010006996
Gene Symbol: DDR2
3 Cross references
190 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSSAUG00010026004
Gene Symbol: LOC115566422
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSSAUG00010027503
Gene Symbol: DRD1
3 Cross references
189 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSSAUG00010016298
Gene Symbol: DRD2
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSSAUG00010014562
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSSAUG00010016818
Gene Symbol: DRD4B
1 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).